Heart Disease Trial, Recruiting NCT06673381 Sponsor: Sohag University Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06673381
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older who have been diagnosed with a serious heart condition called Acute Coronary Syndrome (ACS) and are not able to have a procedure called a primary PCI (a treatment used to open blocked heart arteries).

Who may not be able to join:

  • People under 18 years of age
  • People whose kidneys are not working well enough (as measured by a test called eGFR, which must be 60 or above)
  • People who have been diagnosed with any form of cancer
  • People who have chronic heart failure that is considered moderate to severe (confirm with trial site)
  • People who have chronic liver disease
  • People who have a condition called nephrotic syndrome, which affects the kidneys
  • People who have recently had a stroke
  • People who are pregnant
  • People who have a recent or current infection

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Amira Elbasuony, resident, Sohag University

Phone: 01113695925

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 November 2024
Est. completion
1 November 2024

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

assess the use of hs- C-reactive protein to albumin ratio (hs-CAR) in acute coronary syndrom patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov